schliessen

Filtern

 

Bibliotheken

Aspergillus Bronchitis in Patients with Cystic Fibrosis

Aspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF) and may cause various severe infections, such as bronchitis. Serological data, sputum dependent markers and longitudinal data of treated cases of Aspergillus bronchitis were evaluated for further description... Full description

Journal Title: Mycopathologia 2018, Vol.183(1), pp.61-69
Main Author: Brandt, Claudia
Other Authors: Roehmel, Jobst , Rickerts, Volker , Melichar, Volker , Niemann, Nadja , Schwarz, Carsten
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0301-486X ; E-ISSN: 1573-0832 ; DOI: 10.1007/s11046-017-0190-0
Link: http://dx.doi.org/10.1007/s11046-017-0190-0
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: springer_jour10.1007/s11046-017-0190-0
title: Aspergillus Bronchitis in Patients with Cystic Fibrosis
format: Article
creator:
  • Brandt, Claudia
  • Roehmel, Jobst
  • Rickerts, Volker
  • Melichar, Volker
  • Niemann, Nadja
  • Schwarz, Carsten
subjects:
  • Cystic Fibrosis
  • Aspergillus fumigatus
  • Colonization
  • Bronchitis
  • Pneumonia
ispartof: Mycopathologia, 2018, Vol.183(1), pp.61-69
description: Aspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF) and may cause various severe infections, such as bronchitis. Serological data, sputum dependent markers and longitudinal data of treated cases of Aspergillus bronchitis were evaluated for further description of this infection. This study, which comprises three substudies, aimed to analyze epidemiological data of Aspergillus in CF and the entity of Aspergillus bronchitis. In a first step, data of the German Cystic Fibrosis Registry were used to evaluate the frequency of Aspergillus colonization in patients with CF ( n  = 2599). Then a retrospective analysis of 10 cases of Aspergillus bronchitis was performed to evaluate longitudinal data for lung function and clinical presentation parameters: sputum production, cough and physical capacity. Finally, a prospective cohort study ( n  = 22) was conducted to investigate serological markers for Aspergillus bronchitis: total serum IgE, specific serum IgE, specific serum IgG, as well as sputum galactomannan, real-time PCR detection of Aspergillus DNA in sputum and fungal cultures. Analysis of the German CF registry revealed an Aspergillus colonization rate of 32.5% among the 2599 patients. A retrospective data analysis of 10 treated cases revealed the clinical course of Aspergillus bronchitis, including repeated positive sputum culture findings for A. fumigatus , no antibiotic treatment response, total serum IgE levels
language: eng
source:
identifier: ISSN: 0301-486X ; E-ISSN: 1573-0832 ; DOI: 10.1007/s11046-017-0190-0
fulltext: fulltext
issn:
  • 1573-0832
  • 15730832
  • 0301-486X
  • 0301486X
url: Link


@attributes
ID1437304903
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1007/s11046-017-0190-0
sourceidspringer_jour
recordidTN_springer_jour10.1007/s11046-017-0190-0
sourcesystemOther
pqid1930476515
galeid523793743
display
typearticle
titleAspergillus Bronchitis in Patients with Cystic Fibrosis
creatorBrandt, Claudia ; Roehmel, Jobst ; Rickerts, Volker ; Melichar, Volker ; Niemann, Nadja ; Schwarz, Carsten
ispartofMycopathologia, 2018, Vol.183(1), pp.61-69
identifier
subjectCystic Fibrosis ; Aspergillus fumigatus ; Colonization ; Bronchitis ; Pneumonia
descriptionAspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF) and may cause various severe infections, such as bronchitis. Serological data, sputum dependent markers and longitudinal data of treated cases of Aspergillus bronchitis were evaluated for further description of this infection. This study, which comprises three substudies, aimed to analyze epidemiological data of Aspergillus in CF and the entity of Aspergillus bronchitis. In a first step, data of the German Cystic Fibrosis Registry were used to evaluate the frequency of Aspergillus colonization in patients with CF ( n  = 2599). Then a retrospective analysis of 10 cases of Aspergillus bronchitis was performed to evaluate longitudinal data for lung function and clinical presentation parameters: sputum production, cough and physical capacity. Finally, a prospective cohort study ( n  = 22) was conducted to investigate serological markers for Aspergillus bronchitis: total serum IgE, specific serum IgE, specific serum IgG, as well as sputum galactomannan, real-time PCR detection of Aspergillus DNA in sputum and fungal cultures. Analysis of the German CF registry revealed an Aspergillus colonization rate of 32.5% among the 2599 patients. A retrospective data analysis of 10 treated cases revealed the clinical course of Aspergillus bronchitis, including repeated positive sputum culture findings for A. fumigatus , no antibiotic treatment response, total serum IgE levels <200 kU/l, no observation of new pulmonary infiltrates and appropriate antifungal treatment response. Antifungal treatment durations of 4 ± 1.6 (2–6) weeks significantly reduced cough ( P  = 0.0067), sputum production ( P  < 0.0001) and lung function measures ( P  = 0.0358) but not physical capacity ( P  = 0.0794). From this retrospective study, a prevalence of 1.6% was calculated. In addition, two cases of Aspergillus bronchitis were identified in the prospective cohort study according to immunological, molecular and microbiological parameters. A prevalence of 9% was assessed. Aspergillus bronchitis appears to occur in a minority of colonized CF patients. Antifungal treatment may reduce respiratory symptoms and restore lung function.
languageeng
source
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1007/s11046-017-0190-0$$EView_full_text_in_Springer_(Subscribers_only)
search
creatorcontrib
0Brandt, Claudia
1Roehmel, Jobst
2Rickerts, Volker
3Melichar, Volker
4Niemann, Nadja
5Schwarz, Carsten
titleAspergillus Bronchitis in Patients with Cystic Fibrosis
descriptionAspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF) and may cause various severe infections, such as bronchitis. Serological data, sputum dependent markers and longitudinal data of treated cases of Aspergillus bronchitis were evaluated for further description of this infection. This study, which comprises three substudies, aimed to analyze epidemiological data of Aspergillus in CF and the entity of Aspergillus bronchitis. In a first step, data of the German Cystic Fibrosis Registry were used to evaluate the frequency of Aspergillus colonization in patients with CF ( n  = 2599). Then a retrospective analysis of 10 cases of Aspergillus bronchitis was performed to evaluate longitudinal data for lung function and clinical presentation parameters: sputum production, cough and physical capacity. Finally, a prospective cohort study ( n  = 22) was conducted to investigate serological markers for Aspergillus bronchitis: total serum IgE, specific serum IgE, specific serum IgG, as well as sputum galactomannan, real-time PCR detection of Aspergillus DNA in sputum and fungal cultures. Analysis of the German CF registry revealed an Aspergillus colonization rate of 32.5% among the 2599 patients. A retrospective data analysis of 10 treated cases revealed the clinical course of Aspergillus bronchitis, including repeated positive sputum culture findings for A. fumigatus , no antibiotic treatment response, total serum IgE levels <200 kU/l, no observation of new pulmonary infiltrates and appropriate antifungal treatment response. Antifungal treatment durations of 4 ± 1.6 (2–6) weeks significantly reduced cough ( P  = 0.0067), sputum production ( P  < 0.0001) and lung function measures ( P  = 0.0358) but not physical capacity ( P  = 0.0794). From this retrospective study, a prevalence of 1.6% was calculated. In addition, two cases of Aspergillus bronchitis were identified in the prospective cohort study according to immunological, molecular and microbiological parameters. A prevalence of 9% was assessed. Aspergillus bronchitis appears to occur in a minority of colonized CF patients. Antifungal treatment may reduce respiratory symptoms and restore lung function.
subject
0Cystic Fibrosis
1Aspergillus fumigatus
2Colonization
3Bronchitis
4Pneumonia
general
010.1007/s11046-017-0190-0
1English
2Springer Science & Business Media B.V.
3SpringerLink
sourceidspringer_jour
recordidspringer_jour10.1007/s11046-017-0190-0
issn
01573-0832
115730832
20301-486X
30301486X
rsrctypearticle
creationdate2018
addtitleMycopathologia
searchscopespringer_journals_complete
scopespringer_journals_complete
lsr30VSR-Enriched:[galeid, orcidid, pages, pqid]
sort
titleAspergillus Bronchitis in Patients with Cystic Fibrosis
authorBrandt, Claudia ; Roehmel, Jobst ; Rickerts, Volker ; Melichar, Volker ; Niemann, Nadja ; Schwarz, Carsten
creationdate20180200
facets
frbrgroupid-5251385643267306958
frbrtype5
newrecords20180124
languageeng
creationdate2018
topic
0Cystic Fibrosis
1Aspergillus Fumigatus
2Colonization
3Bronchitis
4Pneumonia
collectionSpringerLink
prefilterarticles
rsrctypearticles
creatorcontrib
0Brandt, Claudia
1Roehmel, Jobst
2Rickerts, Volker
3Melichar, Volker
4Niemann, Nadja
5Schwarz, Carsten
jtitleMycopathologia
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Brandt
1Roehmel
2Rickerts
3Melichar
4Niemann
5Schwarz
aufirst
0Claudia
1Jobst
2Volker
3Nadja
4Carsten
au
0Brandt, Claudia
1Roehmel, Jobst
2Rickerts, Volker
3Melichar, Volker
4Niemann, Nadja
5Schwarz, Carsten
atitleAspergillus Bronchitis in Patients with Cystic Fibrosis
jtitleMycopathologia
stitleMycopathologia
risdate201802
volume183
issue1
spage61
epage69
issn0301-486X
eissn1573-0832
genrearticle
ristypeJOUR
abstractAspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF) and may cause various severe infections, such as bronchitis. Serological data, sputum dependent markers and longitudinal data of treated cases of Aspergillus bronchitis were evaluated for further description of this infection. This study, which comprises three substudies, aimed to analyze epidemiological data of Aspergillus in CF and the entity of Aspergillus bronchitis. In a first step, data of the German Cystic Fibrosis Registry were used to evaluate the frequency of Aspergillus colonization in patients with CF ( n  = 2599). Then a retrospective analysis of 10 cases of Aspergillus bronchitis was performed to evaluate longitudinal data for lung function and clinical presentation parameters: sputum production, cough and physical capacity. Finally, a prospective cohort study ( n  = 22) was conducted to investigate serological markers for Aspergillus bronchitis: total serum IgE, specific serum IgE, specific serum IgG, as well as sputum galactomannan, real-time PCR detection of Aspergillus DNA in sputum and fungal cultures. Analysis of the German CF registry revealed an Aspergillus colonization rate of 32.5% among the 2599 patients. A retrospective data analysis of 10 treated cases revealed the clinical course of Aspergillus bronchitis, including repeated positive sputum culture findings for A. fumigatus , no antibiotic treatment response, total serum IgE levels <200 kU/l, no observation of new pulmonary infiltrates and appropriate antifungal treatment response. Antifungal treatment durations of 4 ± 1.6 (2–6) weeks significantly reduced cough ( P  = 0.0067), sputum production ( P  < 0.0001) and lung function measures ( P  = 0.0358) but not physical capacity ( P  = 0.0794). From this retrospective study, a prevalence of 1.6% was calculated. In addition, two cases of Aspergillus bronchitis were identified in the prospective cohort study according to immunological, molecular and microbiological parameters. A prevalence of 9% was assessed. Aspergillus bronchitis appears to occur in a minority of colonized CF patients. Antifungal treatment may reduce respiratory symptoms and restore lung function.
copDordrecht
pubSpringer Netherlands
doi10.1007/s11046-017-0190-0
orcidid0000-0003-3474-2857
pages61-69
date2018-02